What is ALJ Hearing (Medicare Level 3 Appeal)? Definition, Formula, and Benchmark

An ALJ Hearing is the third level of the Medicare claim appeals process, conducted before an Administrative Law Judge (ALJ) at the Office of Medicare Hearings and Appeals (OMHA). ALJ hearings follow an unfavorable QIC Reconsideration and provide an independent judicial-style review of Medicare claims disputes. ALJ hearings include live testimony, evidence presentation, and legal argument, representing the most procedurally formal level of the Medicare appeals ladder below federal court.

Eligibility requires an amount-in-controversy (AIC) threshold, adjusted annually by CMS based on the medical care component of the Consumer Price Index. The AIC threshold for 2026 is approximately $180. Individual claim denials below the threshold may be aggregated to meet the threshold when the claims involve common issues of law and fact. Appellants must request the ALJ hearing within 60 days of receiving the QIC Reconsideration notice.

Hearing procedure typically involves: initial submission of request and appeal record, case assignment to an ALJ, scheduling of hearing (video, telephone, or in-person), hearing with testimony and evidence, and issuance of written decision. ALJ decisions must be issued within 90 days of hearing request receipt per CMS regulation, though the 2014–2018 backlog created significant delays. Federal legislation and HHS policy initiatives have since reduced backlog; recent processing times have improved but may exceed 90 days.

Preparation for ALJ hearing is substantial. Organizations typically engage: physician advisors to provide clinical testimony, legal counsel (attorneys or non-attorney representatives qualified under CMS regulations), comprehensive evidence organization including all prior appeal submissions plus new evidence, and pre-hearing briefs articulating the legal and clinical basis for appeal. Strong ALJ cases combine clinical documentation, regulatory analysis, and clear presentation of the denial's procedural and substantive errors.

ALJ overturn rates historically have been higher than lower-level appeal overturn rates, though the rate has fluctuated with CMS policy changes and enforcement priorities. Historical Medicare ALJ overturn rates of 50%+ drove some of the appeals volume that created the 2014 backlog. CMS subsequently modified processes including evidence rules and AIC thresholds; current overturn rates vary by denial category.

For RCM operations, ALJ appeals are a specialized, resource-intensive function concentrated in larger provider organizations with sufficient denial volume to justify in-house expertise or dedicated outside counsel. Most practices outsource ALJ appeals to specialized law firms or appeals vendors. Strategic decisions about ALJ pursuit consider: denial dollar amount (must justify ALJ effort cost), strength of clinical and policy arguments, probability of overturn, and the appellant's broader denial management strategy.

Beyond ALJ, the Medicare appeals ladder includes Medicare Appeals Council review at the HHS Departmental Appeals Board (Level 4) and Federal District Court (Level 5, with amount-in-controversy threshold approximately $1,850 for 2026). Each level has distinct procedural and evidentiary rules; strategic escalation typically reflects both legal merit and dollar amount analysis. Provider organizations with material Medicare denial exposure maintain relationships with specialized healthcare law firms experienced in Medicare appeals for complex high-dollar cases.

The 2014–2018 ALJ backlog, which extended processing times to several years, prompted CMS, HHS, and Congress to implement reforms including Senior Attorney reviewers, modified evidentiary rules, and AIC threshold adjustments. The backlog has since substantially reduced, though processing times continue to exceed regulatory targets for complex cases.